Cite
APA Citation
Zhou, C., Lu, Y., Kim, S., Reungwetwattana, T., Zhou, J., Zhang, Y., He, J., Yang, J., Cheng, Y., Lee, S. H., Bu, L., Xu, T., Yang, L., Wang, C., Morcos, P. N., Mitry, E., & Li, Z. (n.d.). lBA2Primary results of ALESIA: Phase III, randomised open-label study of alectinib (ALC) vs crizotinib (CRZ) in Asian patients (pts) with treatment-naïve ALK+ advanced non-small-cell lung cancer (NSCLC). Annals of oncology, 29, . http://access.bl.uk/ark:/81055/vdc_100095498270.0x000043